Hepcidin regulation in prostate and its disruption in prostate cancer. - Wikidata - awgldk - TriplyDB

Hepcidin regulation in prostate and its disruption in prostate cancer.

Hepcidin regulation in prostate and its disruption in prostate cancer.

http://www.wikidata.org/entity/Q38889135

about

Pharmacological Targeting of the Hepcidin/Ferroportin Axis Targeting iron metabolism in drug discovery and delivery Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth Local iron homeostasis in the breast ductal carcinoma microenvironment.Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease.SOSTDC1 is down-regulated in non-small cell lung cancer and contributes to cancer cell proliferation.Modulation of hepcidin to treat iron deregulation: potential clinical applications.Iron and cancer: recent insights Effects of Anti-repulsive Guidance Molecule C (RGMc/Hemojuvelin) Antibody on Hepcidin and Iron in Mouse Liver and Tumor Xenografts DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.Malignancies and thalassemia: a review of the literature.SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.Iron deposition is associated with differential macrophage infiltration and therapeutic response to iron chelation in prostate cancer.Iron addiction: a novel therapeutic target in ovarian cancer Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer.Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.Dysregulated lncRNA-UCA1 contributes to the progression of gastric cancer through regulation of the PI3K-Akt-mTOR signaling pathway.Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages.Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth.Hepcidin and DNA promoter methylation in hepatocellular carcinoma.Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology.Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications.Increased expression of hepcidin and associated upregulation of JAK/STAT3 signaling in human gastric cancer.Hepcidin, an emerging and important player in brain iron homeostasis.Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.DNA methylation of hepatic iron sensing genes and the regulation of hepcidin expression.Role of hepcidin and iron metabolism in the onset of prostate cancer.Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer.Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer.The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin

P2860

Q26738350-8CE68869-38BF-41ED-A5C1-DB6CA346A09E Q33757232-9E32093A-F5C5-42A1-B710-1C4CDA447CAD Q36046653-6541E800-F85F-4B19-909C-219763300334 Q36654277-E0BB3796-D5B5-4034-A71F-4763AEBDFBB0 Q36665139-9354FDD1-1116-4409-9004-4A25F8C1E418 Q36800327-BC9401A9-B60D-4A50-8063-6F5D6EC16F47 Q36847852-464B7E85-B270-4047-A32D-9AC4A1F22769 Q36909297-030DCE8A-C283-4799-A3AE-72E3797060E7 Q37638804-F66A9BB9-9D3D-4364-A45C-E8661417F792 Q37686041-72D76D50-ECD1-44F5-AB1F-0CBE81F1EE07 Q38750541-19CC8598-7EDD-4AB4-AF19-DF3E44654DE6 Q38759773-1CDDB754-7B42-4320-8AFE-08F4E5903F31 Q39313303-CF635C10-41DF-41E6-BAD2-3EA9B31C0CE0 Q41050245-6A3C4BF3-AEE4-4E8F-BC1E-3894E5EF24FD Q41211121-EA19A803-8C2C-4AA3-95B4-0EBD391176FC Q41709616-0BABB8E7-8530-4FE5-A870-AE52F8D53C6D Q47097927-9B50DCCE-BF1B-4471-BC3D-B6AA79FEEBBE Q47139829-95075433-3202-4E66-B184-171716F5AC33 Q47161414-513F5041-53AF-4249-93BA-AB7D735CEB96 Q47164877-99B1E12E-CB5C-4045-A346-853A2DD36914 Q48128368-DE05B47E-4D3D-4730-A9EB-E1C7C4A4DC77 Q48623654-1B89ECC2-F055-49A0-AEE2-AC939191BEE3 Q49389245-ECC85992-3DEE-4BB3-ACC6-E663B7251653 Q49594923-94B61E4B-F466-4E2E-8DD7-112DB7FC3798 Q49885816-6A39912F-0295-4EC1-ACA8-046DB387FEAF Q52562759-85A39225-5798-4F27-88F8-59A1B60EAD19 Q54943445-B0B42766-632D-4595-BB81-E2211EDDCB19 Q55144988-20652679-939C-4AF0-8358-9DABED9AF91C Q55408493-FA609235-2BC5-409A-8F5C-E9C214268678 Q55497286-56FC8F90-EF73-4E66-BE0F-B5BE7A5FD3D4 Q58699655-1F7BA116-6FED-4BAA-AF9C-7E672F55DEF3 Q58700293-93DCBDFB-F04A-4127-8B57-222C6735862F

P2860

Hepcidin regulation in prostate and its disruption in prostate cancer.

http://www.wikidata.org/entity/Q38889135

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Hepcidin regulation in prostate and its disruption in prostate cancer.

@en

type

label

Hepcidin regulation in prostate and its disruption in prostate cancer.

@en

prefLabel

Hepcidin regulation in prostate and its disruption in prostate cancer.

@en

P1433

Q38889135-563ECDCE-44BB-44C8-AC82-946A3DE9D27E

P1476

Q38889135-77C72C47-33A4-4764-8E7B-FEE693BAEBE2

P2093

Q38889135-2D7013A3-1258-4279-AB99-F76C6F5217C6

Q38889135-3515406B-A031-4036-83A2-0BEEC5F0AA3C

Q38889135-3D863EEA-97C9-4551-A6FF-C59B3B4092A7

Q38889135-4726A544-74F6-4CA4-9A1C-E238D0A0EF08

Q38889135-50BF3415-48EA-4CAE-9158-D4C9D1BA4F3F

Q38889135-7669CD22-EFC4-4304-B678-87B767C4DA8C

Q38889135-79FC14F9-BE3A-4933-B2AC-716F85640E95

Q38889135-8263B845-3A51-48C0-B9AC-3E6A6C40E470

Q38889135-8AAE4DFF-4D24-49D0-936A-F3FA927C4880

Q38889135-9AB7D751-BEFE-4B77-9C4E-C7B37391C537

P2860

Q38889135-030ABB03-92D7-4A67-826C-18A4A2134526

Q38889135-043FC7F9-6F2E-4F7C-9A74-D98DF78CD0B0

Q38889135-060776FC-0502-4BD0-9A00-E5D956DE955D

Q38889135-07C642F7-50BC-40B5-9E70-7CC4E0A7202E

Q38889135-10B991FC-35EB-4B0A-8D18-2174FFB9AA92

Q38889135-12F7F333-090F-496F-B673-AF31B3B0A93A

Q38889135-1820B740-941C-4066-AFBC-D93AFD8E656D

Q38889135-1A4E599A-4AE3-49A2-AC8F-BA5AE4BF7BD4

Q38889135-1D01E0A3-B840-43B2-866B-464C93E68CB7

Q38889135-1D03BE00-277B-4B8A-822C-EA659DF8C342

P304

Q38889135-4861AC87-A7D5-498C-9FD0-23C0382875E1

P31

Q38889135-5F3C71C6-63C3-4D08-9DC2-7920D0503E2A

P356

Q38889135-6DF3ADDB-8B20-4903-A2E6-4065154805B4

P407

Q38889135-CB08272F-2B3C-4B98-A4A1-F2CA90E85CA0

P433

Q38889135-E03DF4F8-1718-4A4B-BFB3-E0CA4C146715

P478

Q38889135-4C8BEEAC-CE7E-4E4A-A1F4-A3D89D45B0CD

P50

Q38889135-AD5B95EE-8401-426E-AD87-B07DF52AE856

P577

Q38889135-76A38716-587C-41A2-A35C-94FE3426D99D

P5875

Q38889135-D7FFD0F3-179A-4D57-8CB7-DA720898B46D

P698

Q38889135-B8FC9857-3FD1-4ADA-BA35-4F997547D7DF

P932

Q38889135-3D74F9C3-70B3-4168-B29B-77C8FE7BB951

P356

0008-5472.CAN-14-2465

P1433

Cancer Research

P1476

Hepcidin regulation in prostate and its disruption in prostate cancer

@en

P2093

Cindy K Miranti

http://www.w3.org/2001/XMLSchema#string

Donna M Peehl

http://www.w3.org/2001/XMLSchema#string

Frank M Torti

http://www.w3.org/2001/XMLSchema#string

Herbert Y Lin

http://www.w3.org/2001/XMLSchema#string

Jin Woo Kim

http://www.w3.org/2001/XMLSchema#string

Jodie L Babitt

http://www.w3.org/2001/XMLSchema#string

Kathryn A Clausen

http://www.w3.org/2001/XMLSchema#string

Lia Tesfay

http://www.w3.org/2001/XMLSchema#string

Nicole Blanchette

http://www.w3.org/2001/XMLSchema#string

Poornima Hegde

http://www.w3.org/2001/XMLSchema#string

P2860

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression

Wnt/β-catenin signaling and disease

Hepcidin and iron homeostasis

Cancer statistics, 2014

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney

Ferroportin and iron regulation in breast cancer progression and prognosis

Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer

Integrative genomic profiling of human prostate cancer

P304

2254-2263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-14-2465

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274723446

http://www.w3.org/2001/XMLSchema#string

P698

25858146

http://www.w3.org/2001/XMLSchema#string

P932

4454355

http://www.w3.org/2001/XMLSchema#string